Electrical Impedance Myography Correlates with Functional Measures of Disease Progression in D2-mdx Mice and Boys with Duchenne Muscular Dystrophy

被引:4
|
作者
Chrzanowski, Stephen M. [1 ,2 ]
Nagy, Janice A. [2 ]
Pandeya, Sarbesh [2 ]
Rutkove, Seward B. [2 ]
机构
[1] Boston Childrens Hosp, Dept Neurol, Boston, MA USA
[2] Beth Israel Deaconess Med Ctr, Dept Neurol, 330 Brookline Ave, Boston, MA 02215 USA
关键词
Electrical impedance myography; duchenne muscular dystrophy; D2-mdx mice; biomarker; functional outcome measures; HELD ELECTRODE ARRAY; QUANTITATIVE ULTRASOUND; MUSCLE; MANAGEMENT; DIAGNOSIS; ATROPHY;
D O I
10.3233/JND-210787
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Sensitive, objective, and longitudinal outcome measures applicable to both pre-clinical and clinical interventions are needed to assess muscle health in Duchenne muscular dystrophy (DMD). Electrical impedance myography (EIM) has the potential to non-invasively measure disease progression in mice and boys with DMD. Objective: We sought to evaluate how electrical impedance values (i.e., phase, reactance, and resistance) correlate to established measures of disease in both D2-mdx and wild type (WT) mice and boys with and without DMD. Methods: Histological, functional, and EIM data collected from previous studies of WT and D2-mdx mice at 6, 13, 21 and 43 weeks of age were reanalyzed. In parallel, previously collected functional outcome measures and EIM values were reanalyzed from boys with and without DMD at four different age groups from 2 to 14 years old. Results: In mice, disease progression as detected by histological, functional, andEIMmeasures, was appreciable over this time period and grip strength best correlated to longitudinal phase and reactance impedance values. In boys, disease progression quantified through commonly utilized functional outcome measures was significant and longitudinal phase demonstrated the strongest correlation with functional outcome measures. Conclusion: Similar changes in EIM values, specifically in longitudinal reactance and phase, were found to show significant correlations to functional measures in both mice and boys. Thus, EIM demonstrates applicability in both pre-clinical and clinical settings and can be used as a safe, non-invasive, and longitudinal proxy biomarker to assess muscle health in DMD.
引用
收藏
页码:81 / 90
页数:10
相关论文
共 50 条
  • [41] Treatment of young boys with Duchenne muscular dystrophy with the NF-κB inhibitor edasalonexent showed a slowing of disease progression as assessed by MRI and functional measures
    Finkel, R.
    Vandenborne, K.
    Sweeney, H.
    Finanger, E.
    Tennekoon, G.
    Shieh, P.
    Willcocks, R.
    Walter, G.
    Rooney, W.
    Forbes, S.
    Triplett, W.
    Yum, S.
    Mancini, M.
    MacDougall, J.
    Fretzen, A.
    Bista, P.
    Nichols, A.
    Donovan, J.
    NEUROMUSCULAR DISORDERS, 2019, 29 : S208 - S208
  • [42] Potential benefits of JMV2894, a growth hormone secretagogue, in Duchenne muscular dystrophy: insights from a preclinical study in the D2-mdx mouse
    Mantuano, P.
    Boccanegra, B.
    Cappellari, O.
    Mele, A.
    Marinelli, M.
    Cristiano, E.
    Tulimiero, L.
    Conte, E.
    Torsello, A.
    Denoyelle, S.
    Liantonio, A.
    De Luca, A.
    NEUROMUSCULAR DISORDERS, 2024, 43
  • [43] Sunitinib promotes myogenic regeneration and mitigates disease progression in the mdx mouse model of Duchenne muscular dystrophy
    Fontelonga, Tatiana M.
    Jordan, Brennan
    Nunes, Andreia M.
    Barraza-Flores, Pamela
    Bolden, Nicholas
    Wuebbles, Ryan D.
    Griner, Lesley Mathews
    Hue, Xin
    Ferrer, Marc
    Marugan, Juan
    Southall, Noel
    Burkin, Dean J.
    HUMAN MOLECULAR GENETICS, 2019, 28 (13) : 2120 - 2132
  • [44] Longitudinal measurements of MRI-T2 in boys with Duchenne muscular dystrophy: Effects of age and disease progression
    Willcocks, R. J.
    Arpan, I. A.
    Forbes, S. C.
    Lott, D. J.
    Senesac, C. R.
    Senesac, E.
    Deol, J.
    Triplett, W. T.
    Baligand, C.
    Daniels, M. J.
    Sweeney, H. L.
    Walter, G. A.
    Vandenborne, K.
    NEUROMUSCULAR DISORDERS, 2014, 24 (05) : 393 - 401
  • [45] Insights from a multisite study utilizing dedicated technology to assess electrical impedance myography as an outcome measure for Duchenne muscular dystrophy
    Zaidman, C.
    Kapur, K.
    Darras, B.
    Wong, B.
    Yang, M.
    Leitner, M.
    Pazze, L. Dalle
    Buck, M.
    Freedman, L.
    Rutkove, S.
    NEUROMUSCULAR DISORDERS, 2018, 28 : S126 - S127
  • [46] Cross-sectional Evaluation of Electrical Impedance Myography and Quantitative Ultrasound for the Assessment of Duchenne Muscular Dystrophy in a Clinical Trial Setting
    Rutkove, Seward B.
    Geisbush, Tom R.
    Mijailovic, Aleksandar
    Shklyar, Irina
    Pasternak, Amy
    Visyak, Nicole
    Wu, Jim S.
    Zaidman, Craig
    Darras, Basil T.
    PEDIATRIC NEUROLOGY, 2014, 51 (01) : 88 - 92
  • [47] Participation in daily life activities and its relationship to strength and functional measures in boys with Duchenne muscular dystrophy
    Bendixen, Roxanna M.
    Lott, Donovan J.
    Senesac, Claudia
    Mathur, Sunita
    Vandenborne, Krista
    DISABILITY AND REHABILITATION, 2014, 36 (22) : 1918 - 1923
  • [48] Muscle ultrasound quantifies disease progression over time in infants and young boys with duchenne muscular dystrophy
    Zaidman, Craig M.
    Malkus, Elizabeth C.
    Connolly, Anne M.
    MUSCLE & NERVE, 2015, 52 (03) : 334 - 338
  • [49] Wheat kernel ingestion protects from progression of muscle weakness in mdx mice, an animal model of Duchenne muscular dystrophy
    Hubner, C
    Lehr, HA
    Bodlaj, R
    Finckh, B
    Oexle, K
    Marklund, SL
    Freudenberg, K
    Kontush, A
    Speer, A
    Terwolbeck, K
    Voit, T
    Kohlschutter, A
    PEDIATRIC RESEARCH, 1996, 40 (03) : 444 - 449
  • [50] Step Activity Monitoring in Boys with Duchenne Muscular Dystrophy and its Correlation with Magnetic Resonance Measures and Functional Performance
    Nair, Kavya S.
    Lott, Donovan J.
    Forbes, Sean C.
    Barnard, Alison M.
    Willcocks, Rebecca J.
    Senesac, Claudia R.
    Daniels, Michael J.
    Harrington, Ann T.
    Tennekoon, Gihan, I
    Zilke, Kirsten
    Finanger, Erika L.
    Finkel, Richard S.
    Rooney, William D.
    Walter, Glenn A.
    Vandenborne, Krista
    JOURNAL OF NEUROMUSCULAR DISEASES, 2022, 9 (03) : 423 - 436